US Military's Testosterone Policy Reveals Structural Priorities Over Evidence-Based Health Care
Original framing: “Should testosterone be in Hegseth’s build-your-own-warrior playbook?” — Financial Times
Enlisted service members, especially women, LGBTQ+ personnel, and those from lower socioeconomic backgrounds, are often excluded from decision‑making yet bear the health burdens of hormonal policies. Veteran advocacy groups have reported higher rates of endocrine disorders among those exposed to experimental supplements. Amplifying these marginalized voices is critical for equitable policy reform.
The push to embed testosterone within the U.S. military's performance playbook reflects a deep‑seated alignment of masculinity, institutional power, and profit, echoing historic patterns of drug‑enhanced warfare.
By foregrounding Indigenous holistic health concepts, cross‑cultural warrior ethics, and marginalized service members' lived experiences, we uncover a systemic bias that privileges short‑term combat narratives over long‑term wellbeing. Scientific evidence, artistic critique, and future scenario modeling converge to demonstrate that pharmacological shortcuts risk both individual health and collective readiness. Implementing independent oversight, holistic resilience training, and inclusive voice mechanisms can reorient the defense health system toward evidence‑based, equitable, and sustainable practices.